Please assess the completion status of the following clinical trial:

Trial Title: Schizophrenic Patients Taking Part in Integrated Care Program

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Outpatients suffering from schizophrenia, schizoaffective disorder, schizophreni-form disorder, delusional disorder or psychotic disorder not otherwise specified~* Age 18 - 65 years~* Current stable treatment with Seroquel according to SmPC since at least 2 months~* Given consent to take part in an integrated care program prior to study startWritten informed consent to take part in this NIS~Exclusion Criteria:~* Presence of any contraindication as described in the SmPC~* Cancellation of participation in the integrated care program

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- All (Type: None): Schizophrenic outpatients who are treated with Seroquel IR and who are additionally intended to start with an integrated care program

Based on this trial design, predict the completion outcome and termination type (if applicable).